NDC Directory Finished Products
Table of FINISHED Products
| NDC | Proprietary Name | Non-Proprietary Name | Dosage Form | Route Name | Labeler Name | RxNorm | Status | |
|---|---|---|---|---|---|---|---|---|
| 0074-0817 | Humira | Adalimumab | Kit | Abbvie Inc. | ACTIVE | |||
| 0074-1017 | Oriahnn | Elagolix And Estradiol And Norethisterone | Kit | Abbvie Inc. | ACTIVE | |||
| 0074-1040 | Survanta | Beractant | Suspension | Endotracheal | Abbvie Inc. | ACTIVE | ||
| 0074-1043 | Rinvoq | Upadacitinib | Tablet, Extended Release | Oral | Abbvie Inc. | ACTIVE | ||
| 0074-1044 | Emrelis | Telisotuzumab Vedotin | Injection, Powder, Lyophilized, For Solution | Intravenous | Abbvie Inc. | ACTIVE | ||
| 0074-1050 | Skyrizi | Risankizumab-rzaa | Injection | Subcutaneous | Abbvie Inc. | ACTIVE | ||
| 0074-1055 | Emrelis | Telisotuzumab Vedotin | Injection, Powder, Lyophilized, For Solution | Intravenous | Abbvie Inc. | ACTIVE | ||
| 0074-1065 | Skyrizi | Risankizumab-rzaa | Kit | Intravenous | Abbvie Inc. | ACTIVE | ||
| 0074-1070 | Skyrizi | Risankizumab-rzaa | Kit | Intravenous | Abbvie Inc. | ACTIVE | ||
| 0074-1539 | Humira | Adalimumab | Kit | Abbvie Inc. | ACTIVE | |||
| 0074-1658 | Zemplar | Paricalcitol | Injection, Solution | Intravenous | Abbvie Inc. | ACTIVE | ||
| 0074-2100 | Skyrizi | Risankizumab-rzaa | Injection | Subcutaneous | Abbvie Inc. | ACTIVE | ||
| 0074-2108 | Lupron Depot-ped | Leuprolide Acetate | Kit | Abbvie Inc. | ACTIVE | |||
| 0074-2282 | Lupron Depot-ped | Leuprolide Acetate | Kit | Abbvie Inc. | ACTIVE | |||
| 0074-2306 | Rinvoq | Upadacitinib | Tablet, Extended Release | Oral | Abbvie Inc. | ACTIVE | ||
| 0074-2310 | Rinvoq | Upadacitinib | Tablet, Extended Release | Oral | Abbvie Inc. | ACTIVE | ||
| 0074-2320 | Rinvoq | Upadacitinib | Solution | Oral | Abbvie Inc. | ACTIVE | ||
| 0074-2340 | Norvir | Ritonavir | Tablet, Film Coated | Oral | Abbvie Inc. | ACTIVE | ||
| 0074-2440 | Lupron Depot-ped | Leuprolide Acetate | Kit | Abbvie Inc. | ACTIVE | |||
| 0074-2540 | Humira | Adalimumab | Kit | Abbvie Inc. | ACTIVE | |||
| 0074-2600 | Mavyret | Glecaprevir And Pibrentasvir | Pellet | Oral | Abbvie Inc. | ACTIVE | ||
| 0074-2625 | Mavyret | Glecaprevir And Pibrentasvir | Tablet, Film Coated | Oral | Abbvie Inc. | ACTIVE | ||
| 0074-3008 | Kaletra | Lopinavir And Ritonavir | Tablet, Film Coated | Oral | Abbvie Inc. | ACTIVE | ||
| 0074-3012 | Duopa | Carbidopa And Levodopa | Suspension | Enteral | Abbvie Inc. | ACTIVE | ||
| 0074-3108 | Gengraf | Cyclosporine | Capsule | Oral | Abbvie Inc. | ACTIVE | ||
| 0074-3109 | Gengraf | Cyclosporine | Capsule | Oral | Abbvie Inc. | ACTIVE | ||
| 0074-3173 | Tricor | Fenofibrate | Tablet | Oral | Abbvie Inc. | ACTIVE | ||
| 0074-3189 | Tricor | Fenofibrate | Tablet | Oral | Abbvie Inc. | ACTIVE | ||
| 0074-3346 | Lupron Depot | Leuprolide Acetate | Kit | Abbvie Inc. | ACTIVE | |||
| 0074-3399 | Norvir | Ritonavir | Powder | Oral | Abbvie Inc. | ACTIVE | ||
| 0074-3473 | Lupron Depot | Leuprolide Acetate | Kit | Abbvie Inc. | ACTIVE | |||
| 0074-3575 | Lupron Depot-ped | Leuprolide Acetate | Kit | Abbvie Inc. | ACTIVE | |||
| 0074-3641 | Lupron Depot | Leuprolide Acetate | Kit | Abbvie Inc. | ACTIVE | |||
| 0074-3642 | Lupron Depot | Leuprolide Acetate | Kit | Abbvie Inc. | ACTIVE | |||
| 0074-3663 | Lupron Depot | Leuprolide Acetate | Kit | Abbvie Inc. | ACTIVE | |||
| 0074-3683 | Lupron Depot | Leuprolide Acetate | Kit | Abbvie Inc. | ACTIVE | |||
| 0074-3727 | Synthroid | Levothyroxine Sodium | Tablet | Oral | Abbvie Inc. | ACTIVE | ||
| 0074-3779 | Lupron Depot-ped | Leuprolide Acetate | Kit | Abbvie Inc. | ACTIVE | |||
| 0074-3799 | Humira | Adalimumab | Kit | Abbvie Inc. | ACTIVE | |||
| 0074-3878 | Emblaveo | Aztreonam And Avibactam | Powder, For Solution | Intravenous | Abbvie Inc. | ACTIVE | ||
| 0074-3956 | Kaletra | Lopinavir And Ritonavir | Solution | Oral | Abbvie Inc. | ACTIVE | ||
| 0074-4014 | Kaletra | Lopinavir And Ritonavir | Tablet, Film Coated | Oral | Abbvie Inc. | ACTIVE | ||
| 0074-4339 | Humira | Adalimumab | Kit | Abbvie Inc. | ACTIVE | |||
| 0074-4341 | Synthroid | Levothyroxine Sodium | Tablet | Oral | Abbvie Inc. | ACTIVE | ||
| 0074-4456 | Ultane | Sevoflurane | Liquid | Respiratory (inhalation) | Abbvie Inc. | ACTIVE | ||
| 0074-4456 | Ultane | Sevoflurane | Liquid | Respiratory (inhalation) | Abbvie Inc. | ACTIVE | ||
| 0074-4552 | Synthroid | Levothyroxine Sodium | Tablet | Oral | Abbvie Inc. | ACTIVE | ||
| 0074-4637 | Zemplar | Paricalcitol | Injection, Solution | Intravenous | Abbvie Inc. | ACTIVE | ||
| 0074-5015 | Skyrizi | Risankizumab-rzaa | Injection | Intravenous | Abbvie Inc. | ACTIVE | ||
| 0074-5182 | Synthroid | Levothyroxine Sodium | Tablet | Oral | Abbvie Inc. | ACTIVE | ||
| 0074-6114 | Depakote Sprinkles | Divalproex Sodium | Capsule | Oral | Abbvie Inc. | ACTIVE | ||
| 0074-6594 | Synthroid | Levothyroxine Sodium | Tablet | Oral | Abbvie Inc. | ACTIVE | ||
| 0074-6624 | Synthroid | Levothyroxine Sodium | Tablet | Oral | Abbvie Inc. | ACTIVE | ||
| 0074-6799 | Kaletra | Lopinavir And Ritonavir | Tablet, Film Coated | Oral | Abbvie Inc. | ACTIVE | ||
| 0074-7040 | Skyrizi | Risankizumab-rzaa | Kit | Abbvie Inc. | ACTIVE | |||
| 0074-7042 | Skyrizi | Risankizumab-rzaa | Kit | Abbvie Inc. | ACTIVE | |||
| 0074-7068 | Synthroid | Levothyroxine Sodium | Tablet | Oral | Abbvie Inc. | ACTIVE | ||
| 0074-7069 | Synthroid | Levothyroxine Sodium | Tablet | Oral | Abbvie Inc. | ACTIVE | ||
| 0074-7070 | Synthroid | Levothyroxine Sodium | Tablet | Oral | Abbvie Inc. | ACTIVE | ||
| 0074-7094 | Qulipta | Atogepant | Tablet | Oral | Abbvie Inc. | ACTIVE | ||
| 0074-7095 | Qulipta | Atogepant | Tablet | Oral | Abbvie Inc. | ACTIVE | ||
| 0074-7096 | Qulipta | Atogepant | Tablet | Oral | Abbvie Inc. | ACTIVE | ||
| 0074-7098 | Vuity | Pilocarpine Hydrochloride | Solution/ Drops | Ophthalmic | Abbvie Inc. | ACTIVE | ||
| 0074-7148 | Synthroid | Levothyroxine Sodium | Tablet | Oral | Abbvie Inc. | ACTIVE | ||
| 0074-7149 | Synthroid | Levothyroxine Sodium | Tablet | Oral | Abbvie Inc. | ACTIVE | ||
| 0074-7269 | Gengraf | Cyclosporine | Solution | Oral | Abbvie Inc. | ACTIVE | ||
| 0074-7325 | Depakote | Divalproex Sodium | Tablet, Delayed Release | Oral | Abbvie Inc. | ACTIVE | ||
| 0074-7326 | Depakote | Divalproex Sodium | Tablet, Delayed Release | Oral | Abbvie Inc. | ACTIVE | ||
| 0074-7327 | Depakote | Divalproex Sodium | Tablet, Delayed Release | Oral | Abbvie Inc. | ACTIVE | ||
| 0074-7401 | Depakote ER | Divalproex Sodium | Tablet, Extended Release | Oral | Abbvie Inc. | ACTIVE | ||
| 0074-7402 | Depakote ER | Divalproex Sodium | Tablet, Extended Release | Oral | Abbvie Inc. | ACTIVE | ||
| 0074-8300 | Skyrizi | Risankizumab-rzaa | Injection | Subcutaneous | Abbvie Inc. | ACTIVE | ||
| 0074-8350 | Skyrizi | Risankizumab-rzaa | Injection | Subcutaneous | Abbvie Inc. | ACTIVE | ||
| 0074-9036 | Zemplar | Paricalcitol | Capsule, Liquid Filled | Oral | Abbvie Inc. | ACTIVE | ||
| 0074-9037 | Zemplar | Paricalcitol | Capsule, Liquid Filled | Oral | Abbvie Inc. | ACTIVE | ||
| 0074-9296 | Synthroid | Levothyroxine Sodium | Tablet | Oral | Abbvie Inc. | ACTIVE | ||
| 0074-9694 | Lupron Depot-ped | Leuprolide Acetate | Kit | Abbvie Inc. | ACTIVE | |||
| 0075-0620 | Lovenox | Enoxaparin Sodium | Injection | Subcutaneous | Sanofi-aventis U.s. Llc | ACTIVE | ||
| 0075-0621 | Lovenox | Enoxaparin Sodium | Injection | Subcutaneous | Sanofi-aventis U.s. Llc | ACTIVE | ||
| 0075-0622 | Lovenox | Enoxaparin Sodium | Injection | Subcutaneous | Sanofi-aventis U.s. Llc | ACTIVE | ||
| 0075-0623 | Lovenox | Enoxaparin Sodium | Injection | Subcutaneous | Sanofi-aventis U.s. Llc | ACTIVE | ||
| 0075-0624 | Lovenox | Enoxaparin Sodium | Injection | Subcutaneous | Sanofi-aventis U.s. Llc | ACTIVE | ||
| 0075-0626 | Lovenox | Enoxaparin Sodium | Injection | Intravenous; Subcutaneous | Sanofi-aventis U.s. Llc | ACTIVE | ||
| 0075-2912 | Lovenox | Enoxaparin Sodium | Injection | Subcutaneous | Sanofi-aventis U.s. Llc | ACTIVE | ||
| 0075-2915 | Lovenox | Enoxaparin Sodium | Injection | Subcutaneous | Sanofi-aventis U.s. Llc | ACTIVE | ||
| 0075-8013 | Lovenox | Enoxaparin Sodium | Injection | Subcutaneous | Sanofi-aventis U.s. Llc | ACTIVE | ||
| 0075-8014 | Lovenox | Enoxaparin Sodium | Injection | Subcutaneous | Sanofi-aventis U.s. Llc | ACTIVE | ||
| 0075-8016 | Lovenox | Enoxaparin Sodium | Injection | Subcutaneous | Sanofi-aventis U.s. Llc | ACTIVE | ||
| 0075-8018 | Lovenox | Enoxaparin Sodium | Injection | Subcutaneous | Sanofi-aventis U.s. Llc | ACTIVE | ||
| 0075-8020 | Lovenox | Enoxaparin Sodium | Injection | Subcutaneous | Sanofi-aventis U.s. Llc | ACTIVE | ||
| 0075-8022 | Lovenox | Enoxaparin Sodium | Injection | Subcutaneous | Sanofi-aventis U.s. Llc | ACTIVE | ||
| 0075-8025 | Lovenox | Enoxaparin Sodium | Injection | Subcutaneous | Sanofi-aventis U.s. Llc | ACTIVE | ||
| 0075-8030 | Lovenox | Enoxaparin Sodium | Injection | Intravenous; Subcutaneous | Sanofi-aventis U.s. Llc | ACTIVE | ||
| 0078-0109 | Sandimmune | Cyclosporine | Injection | Intravenous | Novartis Pharmaceuticals Corporation | ACTIVE | ||
| 0078-0110 | Sandimmune | Cyclosporine | Solution | Oral | Novartis Pharmaceuticals Corporation | ACTIVE | ||
| 0078-0180 | Sandostatin | Octreotide Acetate | Injection, Solution | Intravenous; Subcutaneous | Novartis Pharmaceuticals Corporation | ACTIVE | ||
| 0078-0181 | Sandostatin | Octreotide Acetate | Injection, Solution | Intravenous; Subcutaneous | Novartis Pharmaceuticals Corporation | ACTIVE | ||
| 0078-0182 | Sandostatin | Octreotide Acetate | Injection, Solution | Intravenous; Subcutaneous | Novartis Pharmaceuticals Corporation | ACTIVE | ||
| 0078-0240 | Sandimmune | Cyclosporine | Capsule, Liquid Filled | Oral | Novartis Pharmaceuticals Corporation | ACTIVE | ||
| 0078-0241 | Sandimmune | Cyclosporine | Capsule, Liquid Filled | Oral | Novartis Pharmaceuticals Corporation | ACTIVE | 
TOTAL FINISHED PRODUCTS: 113,438 
 TOTAL FINISHED PRODUCTS BY TYPE 
 HUMAN OTC DRUG PRODUCTS: 55,507 
 HUMAN PRESCRIPTION DRUG PRODUCTS: 55,086 
 NON-STANDARDIZED ALLERGENIC PRODUCTS: 2,232 
 PLASMA DERIVATIVE PRODUCTS: 326 
 VACCINE PRODUCTS: 141 
 STANDARDIZED ALLERGENIC PRODUCTS: 126 
 CELLULAR THERAPY PRODUCTS: 20